Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer

Cancer Medicine - United Kingdom
doi 10.1002/cam4.1361
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cancerous Inhibitor of Protein Phosphatase 2A Regulates Cisplatin Resistance in Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2018English

ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells

PLoS ONE
Multidisciplinary
2011English

Protein Phosphatase 2A (PP2A): A Key Phosphatase in the Progression of Chronic Obstructive Pulmonary Disease (COPD) to Lung Cancer

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Erlotinib Derivative Inhibits Hepatocellular Carcinoma by Targeting CIP2A to Reactivate Protein Phosphatase 2A

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Protein Phosphatase 2A (PP2A) Regulates Interleukin-4-Mediated STAT6 Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer After Colorectal Liver Metastasectomy

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Shwachman–Bodian–Diamond Syndrome (SBDS) Protein Is a Direct Inhibitor of Protein Phosphatase 2A (PP2A) Activity and Overexpressed in Acute Myeloid Leukaemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

FAM122A, a New Endogenous Inhibitor of Protein Phosphatase 2A

Oncotarget
Oncology
2016English

Protein Phosphatase 2A Signaling in Human Prostate Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy